Literature DB >> 16149015

Platelet function tests and flow cytometry to monitor antiplatelet therapy.

Axel Matzdorff1.   

Abstract

There are numerous methods to measure platelet function in specialized laboratories. They provide valuable results for research or small patient studies, but none of these tests is currently used to guide antiplatelet therapy in routine clinical practice. Aggregometry is the most commonly used test, but this technique is time-consuming and pre-analytical preparation, choice of anticoagulant, and agonist have not been standardized. The Rapid-Platelet-Function-Analyzer uses whole blood to measure glycoprotein (GP) IIb/III inhibitor activity. This test is quick and simple and results for abciximab correlate closely with aggregometry. The platelet function analyzer PFA-100 is a good screening method to detect platelet function defects. The closure time of the PFA is also sensitive for aspirin-resistance that affects many patients. Flow cytometry can monitor a whole panel of platelet activation markers and platelet interactions with other cells. It can quantitate receptor expression and inhibition. Although cytometry is time-consuming and expensive, it is a valuable tool for research. Platelets have many different functions. This requires specific tests optimized for each of the different functions. Each test has advantages and disadvantages and should be interpreted only in concert with a thorough history and physical examination. The ideal test should be simple, quick, inexpensive, and available on a 24-hour basis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16149015     DOI: 10.1055/s-2005-916672

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  9 in total

Review 1.  Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

Review 2.  [Coronary stents, dual antiplatelet therapy and peri-operative problems].

Authors:  H Metzler; K Huber; S Kozek-Langenecker; M N Vicenzi; A Münch
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

3.  Slippery platelet syndromes in subdural hematoma.

Authors:  Paul Taylor Akins; Kern Hayden Guppy; Kamran Sahrakar; Mark Wade Hawk
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

Review 4.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

Review 5.  Antiplatelet agents for the treatment of deep venous thrombosis.

Authors:  Carolina Dq Flumignan; Luis Cu Nakano; Jose Cc Baptista-Silva; Ronald Lg Flumignan
Journal:  Cochrane Database Syst Rev       Date:  2022-07-25

6.  Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples.

Authors:  Conrad Lacom; Alexander Tolios; Markus W Löffler; Beate Eichelberger; Peter Quehenberger; Eva Schaden; Marion Wiegele
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

7.  Stability validation of paraformaldehyde-fixed samples for the assessment of the platelet PECAM-1, P-selectin, and PAR-1 thrombin receptor by flow cytometry.

Authors:  Oliver D Atar; Christian Eisert; Ilya Pokov; Victor L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

8.  New horizons in platelets flow cytometry.

Authors:  Muhammad Saboor; Moinuddin Moinuddin; Samina Ilyas
Journal:  Malays J Med Sci       Date:  2013-03

9.  Evaluation of the TEG platelet mapping assay in blood donors.

Authors:  Louise Bochsen; Bo Wiinberg; Mads Kjelgaard-Hansen; Daniel A Steinbrüchel; Pär I Johansson
Journal:  Thromb J       Date:  2007-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.